Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 3001 word(s) 3001 2021-01-04 06:40:17 |
2 format correct Meta information modification 3001 2021-01-04 11:02:07 | |
3 format correct Meta information modification 3001 2021-01-04 11:04:58 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Wei, J. Aerobic Exercise-Induced Cardiac Regeneration. Encyclopedia. Available online: (accessed on 19 June 2024).
Wei J. Aerobic Exercise-Induced Cardiac Regeneration. Encyclopedia. Available at: Accessed June 19, 2024.
Wei, Jianshe. "Aerobic Exercise-Induced Cardiac Regeneration" Encyclopedia, (accessed June 19, 2024).
Wei, J. (2021, January 04). Aerobic Exercise-Induced Cardiac Regeneration. In Encyclopedia.
Wei, Jianshe. "Aerobic Exercise-Induced Cardiac Regeneration." Encyclopedia. Web. 04 January, 2021.
Aerobic Exercise-Induced Cardiac Regeneration

The leading cause of heart failure is cardiomyopathy and damage to the cardiomyocytes. Adult mammalian cardiomyocytes have the ability to regenerate, but this cannot wholly compensate for myocardial cell loss after myocardial injury. Studies have shown that exercise has a regulatory role in the activation and promotion of regeneration of healthy and injured adult cardiomyocytes. However, current research on the effects of aerobic exercise in myocardial regeneration is not comprehensive. This study discusses the relationships between aerobic exercise and the regeneration of cardiomyocytes with respect to complex molecular and cellular mechanisms, paracrine factors, transcriptional factors, signaling pathways, and microRNAs that induce cardiac regeneration. The topics discussed herein provide a knowledge base for physical activity-induced cardiomyocyte regeneration, in which exercise enhances overall heart function and improves the efficacy of cardiac rehabilitation.

cardiomyocyte regeneration aerobic exercise signaling pathways molecular mechanism

1. Introduction

Heart failure (HF) is the leading cause of human morbidity and mortality in the world [1]. HF is a clinical syndrome caused by myocardial structural and/or functional abnormality (e.g., abnormalities of the valves, pericardium, endocardium, arrhythmia, and conduction), resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress [2]. Cardiomyopathies are an important cause of HF with decreased ejection fraction. Dilated cardiomyopathies (DCM) induce HF with reduced ejection fraction (HFrEF), while hypertrophic cardiomyopathies (HCM) trigger HF with preserved ejection (HFpEF) [3][4]. About 50% of HF patients die within five years after the initial diagnosis, which exceeds most cancer [5]. HF encompasses various diseases affecting the heart and can lead to fatal cardiac events [1][6]. Death and loss of adult cardiomyocytes and supporting tissues is a primary driver of pathological ventricular remodeling, which ultimately leads to HF. Except for heart transplant surgery, there is currently a lack of effective treatment to supplement injured myocardial cells within the myocardium.

Previous investigations have demonstrated that mammalian hearts have a limited ability to regenerate following myocardial injury. Existing cardiomyocytes are the primary source of regeneration rather than endogenous progenitor cells [7][8][9]. Several DNA isotope quantitative studies have shown that cardiac regeneration is highest in early childhood and reduces gradually to less than 1% in adulthood [10][11]. Stimulating the physiological cardiac growth signaling cascade and preventing cardiomyocyte loss is an effective way to maintain cardiac function in the case of myocardial overload or damage. Theoretically, the ideal treatment strategy for HF is to replace dead cardiomyocytes with neonatal cardiomyocytes, which electro-chemically couple and communicate with healthy tissue to restore the normal physiological function of damaged myocardium [12]. However, current clinical treatment options remain focused on myocardial rescue rather than on replacement [13].

For centuries, the benefits of regular exercise to improve cardiac function and treat heart disease have been recognized [14][15]. Cardiovascular adaptation due to many years of exercise training includes a sustained increase in cardiac output and the dilation of cardiac dimensions by 10–20%. Chronic exercise training preserves the systolic function of the left ventricle and minimizes the impacts of myocardial infarction (MI) in athletes [16]. Exercise may also attenuate the pathological process and lay the foundation for cardiac remodeling. Routine exercise changes the individual cardiovascular profile and reduces the risk of MI by ~50% for coronary artery disease [17]. Besides improving cardiac function in physiological and pathological settings, regular exercise also increases myocardial mass, likely due to the increase in myocardial cell size [18]. From a cellular-mechanistic perspective, several investigations have found that transcription factors related to cell proliferation and differentiation dramatically increase the expression of exercised hearts [19][20]. These studies suggest that exercise may impact the cell cycle phase of existing cardiomyocytes and promote their re-entry into the cell cycle. Additionally, the reduction of metabolic regulators expression, adipose triglyceride lipase (ATGL/bmm) and transcriptional cofactor PGC-1 is associated with heart dysfunction and lipotoxic cardiomyopathy with elevated systemic H3K27 trimethylation by high-fat-diet (HFD) [21]. A rapid shift from anaerobic glycolysis to fatty acid β-oxidation in myocardium after birth is thought to play a role in cardiomyocyte cell-cycle arrest by induction of DNA damage response pathway in mammalian heart [22]. Inhibiting fatty-acid utilization by pyruvate dehydrogenase kinase 4 (PDK4) delete resulted in pyruvate dehydrogenase activity increase, cardiomyocyte size reduction, DNA damage relief and an increase in cardiomyocyte proliferation [22]. Exercise also could regulate glycolysis [23] and fatty acid metabolism [24] to promote cardiac growth. Numerous studies have indicated that exercise regulates complex molecular pathways and cellular mechanisms (signaling pathways, paracrine factors, transcriptional factors, microRNAs (miRNAs)) that induce cardiac regeneration [20][25][26]. An in-depth understanding of the development of new cardiomyocytes caused by exercise will enable us to develop new therapies for heart disease.

2. Molecular Mechanisms Related to Aerobic Exercise-Induced Cardiac Regeneration

Although human experiments can provide valuable evidence of how exercise influences cardiac regeneration, the limited ability to acquire cardiac tissue is a significant obstacle to exploring the molecular mechanisms of exercise-induced cardiac regeneration. Many studies have shown that the limited capacity of cardiomyocytes to regenerate is enhanced by endurance exercises, such as running and swimming [25][27]. As the most commonly used animal models, rodents (especially mice and rats) have four-chambered hearts that share up to 94% of DNA with humans [28]. Due to their relatively short lifespans, genetic operability, and similar physiological cardiac responses as humans, rodent models are particularly suitable for preclinical study [29][30]. Exercise programs designed for rodents to mimic the effects of exercise on humans include three types of chronic aerobic models, treadmill running, voluntary freewheel running, and swim training [31]. In the running exercise model, exercise intensity is adjusted by controlling the speed, inclination, duration, and interval of the treadmill. The modulation of intensity in the rodent swimming exercise model is changed by the weight of tail loading and exercise duration. The intervention of multiple exercise methods provides a reproducible increase in heart weights from 12–29% and an increase in cardiomyocyte dimension from 17–32% in rodents [32]. Therefore, rodent models offer a valid tool for studying the mechanisms of exercise-induced cardiac regeneration. At present, the mechanism of aerobic exercise-induced myocardial regeneration has mainly focused on paracrine factors, signaling pathways, and miRNAs (Figure 1). Therefore, in this section, we explore the relationship between aerobic exercise and the molecular mechanisms of cardiomyocyte regeneration.

Figure 1. Schematic of major signaling pathways and other factors involved in aerobic exercise-induced cardiomyocyte regeneration. IGF-1 and neuregulin-1 activate PI3K and downstream Akt signaling pathways. Akt activates 4EBP1 and S6K1, downstream signaling molecules of mTOR, which act as crucial factors governing protein biosynthesis in the process of cardiac growth. C/EBPβ and downstream CITED4 are activated by Akt1 and are responsible for cardiomyocyte proliferation. Sirt1 and PGC-1α promote mitochondrial biogenesis. MiR-222 and miR-17-3p have also been shown to regulate the cell cycle and cardiomyocyte proliferation. Akt, RAC-α serine/threonine-protein kinase; C/EBPβ, CCAAT/enhancer-binding protein-β; CITED4, CBP/p300-interacting transactivator with ED-rich carboxy-terminal domain-4; eIF4E, translation initiation factor 4E; IGF-1, insulin growth factor-1; mTOR, mammalian target of rapamycin; PDK1, phosphoinositide-dependent protein kinase-1; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator 1α; PI3K, phosphoinositide 3-kinase; Sirt1, NAD-dependent deacetylase sirtuin1; S6K1, ribosomal protein S6 kinase-β1; 4EBP1, eIF4E-binding protein 1.

2.1. Paracrine Factors

Regarding paracrine factors, insulin-like growth factor-1 (IGF-1) and neuregulin-1 have a specific effect on exercise-induced cardiac regeneration. IGF-1, as a growth factor, is released in response to exercise in animal models and elite athletes [33][34]. Compared with sedentary individuals, increased cardiac IGF-1 is related to heart physiologic growth in trained competitive soccer players [35]. IGF-1 binds to IGF-1 receptor (IGF-1R) and mediates exercise-induced cardiac physiological hypertrophy and cardiomyocyte proliferation by initiating a nexus of intracellular signaling [36][37]. In addition, IGF-1R has also been confirmed to be both necessary and sufficient to mediate physiologic growth in mice [38][39]. Moreover, IGF-1R and insulin receptor (IR) control the cardiac metabolic adjustment to exercise. For example, cardiac-specific IR-deletion in mice increases oxidative stress and mitochondrial energetic impairment [40]. Insulin receptor substrate (IRS) deletion attenuates exercise-induced heart growth and metabolic adaption [41]. The role of IGF-1 up- and down-stream regulators has also been investigated. Notably, phosphoinositide 3-kinase (PI3K)/Akt is the critical pathway that transmits IGF-1 signaling in the context of exercise-induced cardiomyocyte regeneration and heart growth [42]. This will be discussed in detail in the following sections.

Neuregulin-1 stimulates the intracellular PI3K signaling pathway by activating ErbB2/ErbB4 tyrosine kinase receptors. Of note, the neuregulin-1/ErbB2/ErbB4 signaling pathway is essential for cardiomyocyte proliferation and differentiation during development [43]. Accompanied by karyokinesis and cytokinesis, the specific action of neuregulin-1 triggers cardiomyocytes to activate the cell cycle in the S phase, so neuregulin-1 is directly involved in proliferation via cell division in adult cardiomyocytes. Hence, the neuregulin-1/ErbB4 and ErbB2 axes are novel genetic and molecular targets for heart regeneration [44]. Exercise training initiates BrdU- and Ki67-positive cardiomyocyte formation by significantly increasing the expression of IGF-1 and neuregulin-1 in rats [27]. Four weeks of running enhances neuregulin-1 concentrations and stimulates ErbB2, ErbB4, and PI3K/Akt signaling to activate cardiomyocyte regeneration in MI rats [26]. CCAAT/enhancer-binding protein-β (C/EBPβ) is a crucial functional target downstream of the ErbB4 signaling pathway, especially of Akt1 in the heart. As a member of the bHLH gene family of DNA-binding transcription factors, C/EBPβ plays an essential role in cell proliferation and differentiation through cell cycle regulation [45]. C/EBPβ expression is decreased in cardiomyocytes following two weeks of endurance swimming. Interestingly, knockdown of C/EBPβ leads to cardiomyocyte proliferation and gene activation, similar to what is induced by exercise [19]. Strikingly, BrdU-positive cardiomyocytes are increased in exercised and C/EBPβ-downregulated mice. The downregulation of C/EBPβ promotes cardiomyocyte proliferation through the negative regulation of CBP/p300-interacting transactivator with ED-rich carboxy-terminal domain-4 (CITED4), which increases the essential cell cycle/proliferation factor cyclinD1 [19]. However, the specific roles for IGF-1 and neuregulin-1 signaling in exercise-induced cardiomyocyte regeneration need further study.

2.2. PI3K/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway

Many studies based on transgenic mouse models have found that the PI3K-Akt axis plays a vital role in the process of exercise-induced myocardial regeneration [46][47][48][49]. The heterodimeric kinase PI3K is situated in the plasma membrane, and it catalyzes phosphatidylinositol-3,4,5-trisphosphate (PtdIns (3, 4, 5) P3) release. PtdIns (3, 4, 5) P3 is inactivated by lipid phosphatases and tensin homolog (PTEN), which is also an endogenous PI3K inhibitor. Regulatory subunits (p85α, p50α) and catalytic subunits (p110α, p110β, or p110δ) comprise PI3K [42][50]. The overexpression of PI3K (p110α) promoter causes physiological growth but no pathologic hypertrophic growth of the heart in mice [39][42], while dominant-negative PI3K (p110α) transgenic mice do not show physiological hypertrophy stimulated by exercise [42]. Akt, a serine/threonine-protein kinase, is activated by PtdIns (3, 4, 5) P3 and PI3K-dependent PDK1 phosphorylation [51] in normal conditions. Interestingly, Akt1-deletion mice exhibit impaired cardiac growth after 20 days of swimming training but display hypertrophy in the context of aortic banding [47]. As a driver, the PI3K/Akt signaling pathway is involved in cell cycle regulation [52]. Akt has a favorable regulatory effect on the cell cycle by extending the half-life of cyclin D while inhibiting cyclin D1 degradation of PI3K [53].

The mTOR comprises two distinct serine/threonine kinases, mTOR complex 1 and 2 (mTORC1 and mTORC2, respectively), in which the former is sensitive to rapamycin. The Akt/mTOR pathway is activated following exercise training and is a crucial regulator for cardiac physiological growth [51]. Pharmacologic inhibition of mTORC1 with rapamycin can reverse Akt1 overexpression-induced cardiac hypertrophy [54]. A recent study showed that eight weeks of swimming exercise coupled with growth hormone application increases mTOR protein expression levels in the left ventricular tissue of rats [46]. In addition, S6K1 and 4EBP1, mTOR signaling downstream molecules, act as the crucial factors in governing protein biosynthesis in the process of cardiac growth. Swimming exercise in rats for eight weeks induces left ventricular hypertrophy by regulating the gene expression of specific miRNAs that target the PIK3/Akt/mTOR signaling pathway and its negative regulators [48].

2.3. NAD-Dependent Deacetylase Sirtuin1 (Sirt1)/PGC-1α/Akt Signaling Pathway

Mitochondrial functions are adapted to increased energy demand during long-term exercise [55]. Sirt1 is a critical enzyme regulating mitochondrial biogenesis and oxidative stress [56]. Moderate long-term exercise significantly enhances Sirt1 expression and activates its downstream targets, including peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and Akt signaling [57]. PGC-1α is a transcriptional coactivator of nuclear receptors initially recognized as a cold-inducible thermogenic regulator involved in mitochondrial biogenesis in brown fat tissues and skeletal muscle [58]. PGC-1α and PGC-1β-deficient mice have altered mitochondrial function and diminished exercise performance via changes in mitochondrial dynamics and oxidative capacity [59][60][61]. In skeletal muscle, PGC-1 has been shown to mediate mitochondrial adaptations in response to exercise. Acute exercise training significantly increases PGC-1 transcription and mRNA content in the human vastus lateralis muscle [61]. PGC-1α is abundant in the heart after exercise. It plays an essential role in promoting the enhancement in mitochondrial density that increases the efficiency of ATP production through reduced respiratory activity in cardiac myocytes following exercise [41][62][63]. Cardiac PGC-1 plays versatile functions by directly interacting with and activating the downstream cascade of transcription factors [64]. For example, PGC-1 combines with peroxisome proliferator-activated receptor α (PPARα) to adjust fatty acid import, storage, and oxidation in the heart [65][66]. Swimming [67] and running [68] exercise both increase the expression of PGC-1α of the myocardia of mice. HF is related to the downregulation of PGC-1α gene expression [69]. The interconnecting relationship of AMPK-Sirt1 and PGC-1α helps to regulate cardiomyocyte mitochondrial metabolism. Treadmill running promotes AMPK/PGC-1α signal transduction to decrease reactive oxygen species accumulation in rat myocardium [63]. Four weeks of running training can promote the Sirt1/PGC-1α/Akt signaling pathway in cardiomyocytes of MI rats [70]. Although long-term aerobic exercise can enhance resistance against oxidative stress [71][72], there is still no direct evidence in a heart-specific PGC-1-deficient animal model to confirm the necessary role of PGC-1 in the exercise-induced oxidative stress response and cardiomyocyte regeneration.

2.4. miRNAs

miRNAs are small, single-stranded, extremely conserved noncoding RNAs of 21–22 nucleotides that are tightly linked to cardiac disorders. In sports, miRNAs play various roles in exercise-induced cardiomyocyte proliferation and are essential for protecting against pathological cardiac remodeling [20][73][74]. miR-222 is a critical regulator in exercise-induced cardiac regeneration [25]. Swimming exercise increases the expression of miR-222, which induces EdU- and Ki67-positive cardiomyocyte enhancement. In vitro, miR-222 induces a physiologic growth phenotype in cardiomyocytes along with an increased α-MHC/β-MHC ratio and suppresses fetal gene markers like ANF and BNP. MiR-222 also plays a critical role in exercise-induced cardiomyocyte growth after ischemic injury in mice. This effect is mostly mediated by the cell cycle inhibitor p27. Inhibiting the function of miR-222 leads to inhibition of heart growth after exercise [20]. Applying a similar exercise scheme, Shi et al. found that three weeks of endurance exercise increased miR-17-3p, which belongs to the miR-17-92 cluster. TIMP-3 is a target gene of miR-17-3p and indirectly inhibits PTEN. Inhibition of miR-17-3p can attenuate exercise-induced cardiac growth in vivo [73].

Exosomes are small (30–100 nm) endogenous membrane vesicles secreted by most cell types that play a crucial regulatory role in mediating cell-to-cell communication and crosstalk between organs. Exosomes might carry cardioprotective factors induced by remote MI. They also have a favorable effect on oxidative stress following an ischemia-reperfusion injury to the heart. Four weeks of swimming exercise can increase exosomal miR-342-5p, a major cardioprotective factor that inhibits apoptotic signaling (caspase 9 and Jnk2) and enhances survival signaling (p-Akt) in ischemic/reperfused hearts. This has also been confirmed in rowing-trained athletes [75]. Furthermore, ample evidence has confirmed that miRNAs play a vital role in cardiomyocyte regeneration [76][77], which may be related to exercise.

Thus, numerous studies have shown that aerobic exercise can induce the molecular pathways related to cardiomyocyte regeneration, but current studies still lack direct histological evidence. Moreover, further research needs to define the intensity, frequency, and duration of aerobic exercise and explore the precise mechanisms of cell cycle regulation, Wnt/β-catenin signaling [78], the Notch pathway [79], Hippo signaling [80], major paracrine factors, and transcriptional factors on cardiac regeneration.

3. Summary and Future Perspectives

At present, the overwhelming majority of studies support the use of aerobic exercise as a useful intervention to promote cardiomyocyte regeneration under physiological and pathological settings. Among the complex molecular and cellular mechanisms, IGF-1 and neuregulin-1 are the main paracrine factors, the IGF-1/PI3K/Akt axis is the primary signaling pathway, and miR-222 is the main miRNA regulatory factor in aerobic exercise-induced cardiomyocyte regeneration. Although the relative contribution of aerobic exercise-induced cardiomyocyte regeneration is far from clear, some evidence indicates that cardiomyocyte renewal is necessary for mediating the beneficial effect of exercise against cardiac injury. However, translating experimental findings into therapeutic regimens still requires much work to validate their safety and applicability for clinical use.

Although regular and appropriate exercise plays beneficial role in cardiovascular function, prolonged endurance exercise leading to repeated overstimulation and injury might cause inflammation and fibrosis of the atrial, ventricular septum, and right ventricle, which is the basis of atrial and ventricular arrhythmias [81]. Despite aerobic exercise having positive effects on cardiomyocyte regeneration, the unresolved problems related to exercise type, intensity, and duration require further attention. Moreover, is there a specific signaling pathway that causes exercise adaptation in the heart? If so, is it possible to therapeutically stimulate specific signaling pathways to mimic exercise stimulation? In addition, can exercise-induced neonatal cardiomyocytes and the original cardiomyocytes form regular electrical coupling activity restore the contractile activity of a damaged myocardium, thereby promoting the recovery of cardiac function? The underlying mechanisms of exercise-induced cardiac regeneration should be intensively investigated to generate new functional myocardium and improve cardiac function in injured and diseased hearts. Furthermore, cardiomyocyte hypertrophy partly be a compensatory reaction to declining regenerative capability, which seems insufficient counteract an accumulated loss of myocytes with normal aging [7][82]. Exercise significantly attenuated the age-induced increase of apoptosis through ErbB family of tyrosine kinases in cardiomyocytes [83]. Multiple experiment data also indicated that aerobic exercise improved survival of aged cardiomyocytes by increasing Akt activity in senescent rodent hearts [84][85]. Thus, exercise could effectively regulate cardiomyocytes proliferation to resist age-related hypertrophic and apoptosis in heart. Finally, the intervention of exercise as a therapeutic strategy to promote cardiomyocyte regeneration may be affected by numerous factors, including patient condition and exercise program. Therefore, sports medicine experts and clinicians should formulate individualized exercise programs and establish effective evaluation systems. This will provide a strong foundation for the use of exercise as a useful method to promote cardiomyocyte regeneration in patients.


  1. Benjamin, E.J.; Muntner, P.; Alonso, A.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Das, S.R.; et al. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation 2019, 139, e56–e528.
  2. Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.; Coats, A.J.; Falk, V.; Gonzalez-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail 2016, 18, 891–975.
  3. Seferovic, P.M.; Polovina, M.; Bauersachs, J.; Arad, M.; Gal, T.B.; Lund, L.H.; Felix, S.B.; Arbustini, E.; Caforio, A.L.P.; Farmakis, D.; et al. Heart failure in cardiomyopathies: A position paper from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail 2019, 21, 553–576.
  4. Pinto, Y.M.; Elliott, P.M.; Arbustini, E.; Adler, Y.; Anastasakis, A.; Bohm, M.; Duboc, D.; Gimeno, J.; de Groote, P.; Imazio, M.; et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. Eur. Heart J. 2016, 37, 1850–1858.
  5. Askoxylakis, V.; Thieke, C.; Pleger, S.T.; Most, P.; Tanner, J.; Lindel, K.; Katus, H.A.; Debus, J.; Bischof, M. Long-term survival of cancer patients compared to heart failure and stroke: A systematic review. BMC Cancer 2010, 10, 105.
  6. Pinckard, K.; Baskin, K.K.; Stanford, K.I. Effects of exercise to improve cardiovascular health. Front. Cardiovasc. Med. 2019, 6, 69.
  7. Senyo, S.E.; Steinhauser, M.L.; Pizzimenti, C.L.; Yang, V.K.; Cai, L.; Wang, M.; Wu, T.-D.; Guerquin-Kern, J.-L.; Lechene, C.P.; Lee, R.T. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493, 433–436.
  8. Vagnozzi, R.J.; Molkentin, J.D.; Houser, S.R. New myocyte formation in the adult heart: Endogenous sources and therapeutic implications. Circ. Res. 2018, 123, 159–176.
  9. Li, Y.; He, L.; Huang, X.; Bhaloo, S.I.; Zhao, H.; Zhang, S.; Pu, W.; Tian, X.; Li, Y.; Liu, Q.; et al. Genetic lineage tracing of nonmyocyte population by dual recombinases. Circulation 2018, 138, 793–805.
  10. Bergmann, O.; Bhardwaj, R.D.; Bernard, S.; Zdunek, S.; Barnabé-Heider, F.; Walsh, S.; Zupicich, J.; Alkass, K.; Buchholz, B.A.; Druid, H.; et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324, 98–102.
  11. Bergmann, O.; Zdunek, S.; Felker, A.; Salehpour, M.; Alkass, K.; Bernard, S.; Sjostrom, S.L.; Szewczykowska, M.; Jackowska, T.; dos Remedios, C.; et al. Dynamics of cell generation and turnover in the human heart. Cell 2015, 161, 1566–1575.
  12. Cahill, T.J.; Choudhury, R.P.; Riley, P.R. Heart regeneration and repair after myocardial infarction: Translational opportunities for novel therapeutics. Nat. Rev. Drug Discov. 2017, 16, 699–717.
  13. Lázár, E.; Sadek, H.A.; Bergmann, O. Cardiomyocyte renewal in the human heart: Insights from the fall-out. Eur. Heart J. 2017, 38, 2333–2342.
  14. Verdoorn, K.S.; Matsuura, C.; Borges, J.P. Exercise for cardiac health and regeneration: Killing two birds with one stone. Ann. Transl. Med. 2017, 5 (Suppl. 1).
  15. Sanchis-Gomar, F.; Fiuza-Luces, C.; Lucia, A. Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease. Int. J. Cardiol. 2015, 181, 360–361.
  16. Maessen, M.F.H.; Eijsvogels, T.M.H.; Stevens, G.; van Dijk, A.P.J.; Hopman, M.T.E. Benefits of lifelong exercise training on left ventricular function after myocardial infarction. Eur. J. Prev. Cardiol. 2017, 24, 1856–1866.
  17. Sharma, S.; Merghani, A.; Mont, L. Exercise and the heart: The good, the bad, and the ugly. Eur. Heart J. 2015, 36, 1445–1453.
  18. Coats, A.J.S.; Forman, D.E.; Haykowsky, M.; Kitzman, D.W.; McNeil, A.; Campbell, T.S.; Arena, R. Physical function and exercise training in older patients with heart failure. Nat. Rev. Cardiol. 2017, 14, 550–559.
  19. Boström, P.; Mann, N.; Wu, J.; Quintero, P.A.; Plovie, E.R.; Panáková, D.; Gupta, R.K.; Xiao, C.; MacRae, C.A.; Rosenzweig, A.; et al. C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143, 1072–1083.
  20. Liu, X.; Xiao, J.; Zhu, H.; Wei, X.; Platt, C.; Damilano, F.; Xiao, C.; Bezzerides, V.; Boström, P.; Che, L.; et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015, 21, 584–595.
  21. Guida, M.C.; Birse, R.T.; Dall’Agnese, A.; Toto, P.C.; Diop, S.B.; Mai, A.; Adams, P.D.; Puri, P.L.; Bodmer, R. Intergenerational inheritance of high fat diet-induced cardiac lipotoxicity in Drosophila. Nat. Commun. 2019, 10, 193.
  22. Cardoso, A.C.; Lam, N.T.; Savla, J.J.; Nakada, Y.; Pereira, A.H.M.; Elnwasany, A.; Menendez-Montes, I.; Ensley, E.L.; Petric, U.B.; Sharma, G.; et al. Mitochondrial Substrate Utilization Regulates Cardiomyocyte Cell Cycle Progression. Nat. Metab. 2020, 2, 167–178.
  23. Gibb, A.A.; Epstein, P.N.; Uchida, S.; Zheng, Y.; McNally, L.A.; Obal, D.; Katragadda, K.; Trainor, P.; Conklin, D.J.; Brittian, K.R.; et al. Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth. Circulation 2017, 136, 2144–2157.
  24. Hafstad, A.D.; Boardman, N.T.; Lund, J.; Hagve, M.; Khalid, A.M.; Wisloff, U.; Larsen, T.S.; Aasum, E. High intensity interval training alters substrate utilization and reduces oxygen consumption in the heart. J. Appl. Physiol. (1985) 2011, 111, 1235–1241.
  25. Vujic, A.; Lerchenmüller, C.; Wu, T.-D.; Guillermier, C.; Rabolli, C.P.; Gonzalez, E.; Senyo, S.E.; Liu, X.; Guerquin-Kern, J.-L.; Steinhauser, M.L.; et al. Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat. Commun. 2018, 9, 1659.
  26. Cai, M.-X.; Shi, X.-C.; Chen, T.; Tan, Z.-N.; Lin, Q.-Q.; Du, S.-J.; Tian, Z.-J. Exercise training activates neuregulin 1/ErbB signaling and promotes cardiac repair in a rat myocardial infarction model. Life Sci. 2016, 149, 1–9.
  27. Waring, C.D.; Vicinanza, C.; Papalamprou, A.; Smith, A.J.; Purushothaman, S.; Goldspink, D.F.; Nadal-Ginard, B.; Torella, D.; Ellison, G.M. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur. Heart J. 2014, 35, 2722–2731.
  28. Vandamme, T.F. Rodent models for human diseases. Eur. J. Pharmacol. 2015, 759, 84–89.
  29. Roh, J.; Rhee, J.; Chaudhari, V.; Rosenzweig, A. The role of exercise in cardiac aging: From physiology to molecular mechanisms. Circ. Res. 2016, 118, 279–295.
  30. Riehle, C.; Bauersachs, J. Small animal models of heart failure. Cardiovasc. Res. 2019, 115, 1838–1849.
  31. Bernardo, B.C.; McMullen, J.R. Molecular aspects of exercise-induced cardiac remodeling. Cardiol. Clin. 2016, 34, 515–530.
  32. Kemi, O.J.; Loennechen, J.P.; Wisløff, U.; Ellingsen, Ø. Intensity-controlled treadmill running in mice: Cardiac and skeletal muscle hypertrophy. J. Appl. Physiol. 2002, 93, 1301–1309.
  33. Yeh, J.K.; Aloia, J.F.; Chen, M.; Ling, N.; Koo, H.C.; Millard, W.J. Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. Am. J. Physiol. Endocrinol. Metab. 1994, 266, E129–E135.
  34. Koziris, L.P.; Hickson, R.C.; Chatterton, R.T.; Groseth, R.T.; Christie, J.M.; Goldflies, D.G.; Unterman, T.G. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J. Appl. Physiol. 1999, 86, 1436–1442.
  35. Neri Serneri, G.G.; Boddi, M.; Modesti, P.A.; Cecioni, I.; Coppo, M.; Padeletti, L.; Michelucci, A.; Colella, A.; Galanti, G. Increased cardiac sympathetic activity and insulin-like growth factor-i formation are associated with physiological hypertrophy in athletes. Circ. Res. 2001, 89, 977–982.
  36. Ikeda, H.; Shiojima, I.; Ozasa, Y.; Yoshida, M.; Holzenberger, M.; Kahn, C.R.; Walsh, K.; Igarashi, T.; Abel, E.D.; Komuro, I. Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2009, 47, 664–675.
  37. Xin, M.; Kim, Y.; Sutherland, L.B.; Qi, X.; McAnally, J.; Schwartz, R.J.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 2011, 4, ra70.
  38. Kim, J.; Wende, A.R.; Sena, S.; Theobald, H.A.; Soto, J.; Sloan, C.; Wayment, B.E.; Litwin, S.E.; Holzenberger, M.; LeRoith, D.; et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol. Endocrinol. 2008, 22, 2531–2543.
  39. McMullen, J.R.; Shioi, T.; Huang, W.-Y.; Zhang, L.; Tarnavski, O.; Bisping, E.; Schinke, M.; Kong, S.; Sherwood, M.C.; Brown, J.; et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J. Biol. Chem. 2004, 279, 4782–4793.
  40. Boudina, S.; Bugger, H.; Sena, S.; O’Neill, B.T.; Zaha, V.G.; Ilkun, O.; Wright, J.J.; Mazumder, P.K.; Palfreyman, E.; Tidwell, T.J.; et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009, 119, 1272–1283.
  41. Riehle, C.; Wende, A.R.; Zhu, Y.; Oliveira, K.J.; Pereira, R.O.; Jaishy, B.P.; Bevins, J.; Valdez, S.; Noh, J.; Kim, B.J.; et al. Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training. Mol. Cell. Biol. 2014, 34, 3450–3460.
  42. McMullen, J.R.; Shioi, T.; Zhang, L.; Tarnavski, O.; Sherwood, M.C.; Kang, P.M.; Izumo, S. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 2003, 100, 12355–12360.
  43. D’Uva, G.; Aharonov, A.; Lauriola, M.; Kain, D.; Yahalom-Ronen, Y.; Carvalho, S.; Weisinger, K.; Bassat, E.; Rajchman, D.; Yifa, O.; et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat. Cell Biol. 2015, 17, 627–638.
  44. Bersell, K.; Arab, S.; Haring, B.; Kühn, B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138, 257–270.
  45. Sebastian, T.; Johnson, P.F. Stop and go: Anti-proliferative and mitogenic functions of the transcription factor C/EBPβ. Cell Cycle 2006, 5, 953–957.
  46. Palabiyik, O.; Tastekin, E.; Doganlar, Z.B.; Tayfur, P.; Dogan, A.; Vardar, S.A. Alteration in cardiac PI3K/Akt/mTOR and ERK signaling pathways with the use of growth hormone and swimming, and the roles of miR21 and miR133. Biomed. Rep. 2019, 10, 97–106.
  47. DeBosch, B.; Treskov, I.; Lupu, T.S.; Weinheimer, C.; Kovacs, A.; Courtois, M.; Muslin, A.J. Akt1 is required for physiological cardiac growth. Circulation 2006, 113, 2097–2104.
  48. Ma, Z.; Qi, J.; Meng, S.; Wen, B.; Zhang, J. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Eur. J. Appl. Physiol. 2013, 113, 2473–2486.
  49. Medeiros, C.; Frederico, M.J.; da Luz, G.; Pauli, J.R.; Silva, A.S.R.; Pinho, R.A.; Velloso, L.A.; Ropelle, E.R.; De Souza, C.T. Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet-induced obesity rats. J. Cell. Physiol. 2011, 226, 666–674.
  50. Shioi, T.; Kang, P.M.; Douglas, P.S.; Hampe, J.; Yballe, C.M.; Lawitts, J.; Cantley, L.C.; Izumo, S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO 2000, 19, 2537–2548.
  51. Shiojima, I.; Walsh, K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 2006, 20, 3347–3365.
  52. Jia, S.; Liu, Z.; Zhang, S.; Liu, P.; Zhang, L.; Lee, S.H.; Zhang, J.; Signoretti, S.; Loda, M.; Roberts, T.M.; et al. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008, 454, 776–779.
  53. Parekh, P.; Motiwale, L.; Naik, N.; Rao, K.V.K. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp. Toxicol. Pathol. 2011, 63, 167–173.
  54. Shiojima, I.; Sato, K.; Izumiya, Y.; Schiekofer, S.; Ito, M.; Liao, R.; Colucci, W.S.; Walsh, K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Investig. 2005, 115, 2108–2118.
  55. Coronado, M.; Fajardo, G.; Nguyen, K.; Zhao, M.; Kooiker, K.; Jung, G.; Hu, D.-Q.; Reddy, S.; Sandoval, E.; Stotland, A.; et al. Physiological mitochondrial fragmentation is a normal cardiac adaptation to increased energy demand. Circ. Res. 2018, 122, 282–295.
  56. Ruan, Y.; Dong, C.; Patel, J.; Duan, C.; Wang, X.; Wu, X.; Cao, Y.; Pu, L.; Lu, D.; Shen, T.; et al. SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways. Cell. Physiol. Biochem. 2015, 35, 1116–1124.
  57. Bayod, S.; del Valle, J.; Lalanza, J.F.; Sanchez-Roige, S.; de Luxán-Delgado, B.; Coto-Montes, A.; Canudas, A.M.; Camins, A.; Escorihuela, R.M.; Pallàs, M. Long-term physical exercise induces changes in sirtuin 1 pathway and oxidative parameters in adult rat tissues. Exp. Gerontol. 2012, 47, 925–935.
  58. Puigserver, P.; Wu, Z.; Park, C.W.; Graves, R.; Wright, M.; Spiegelman, B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92, 829–839.
  59. Wende, A.R.; Schaeffer, P.J.; Parker, G.J.; Zechner, C.; Han, D.-H.; Chen, M.M.; Hancock, C.R.; Lehman, J.J.; Huss, J.M.; McClain, D.A.; et al. A role for the transcriptional coactivator PGC-1α in muscle refueling. J. Biol. Chem. 2007, 282, 36642–36651.
  60. Zechner, C.; Lai, L.; Zechner, J.F.; Geng, T.; Yan, Z.; Rumsey, J.W.; Collia, D.; Chen, Z.; Wozniak, D.F.; Leone, T.C.; et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 2010, 12, 633–642.
  61. Pilegaard, H.; Saltin, B.; Neufer, P.D. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J. Physiol. 2003, 546, Pt 3, 851–858.
  62. O’Neill, B.T.; Kim, J.; Wende, A.R.; Theobald, H.A.; Tuinei, J.; Buchanan, J.; Guo, A.; Zaha, V.G.; Davis, D.K.; Schell, J.C.; et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab. 2007, 6, 294–306.
  63. Wang, S.Y.; Zhu, S.; Wu, J.; Zhang, M.; Xu, Y.; Xu, W.; Cui, J.; Yu, B.; Cao, W.; Liu, J. Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy. J. Mol. Med. 2020, 98, 245–261.
  64. Vega, R.B.; Horton, J.L.; Kelly, D.P. Maintaining ancient organelles: Mitochondrial biogenesis and maturation. Circ. Res. 2015, 116, 1820–1834.
  65. Finck, B.N.; Lehman, J.J.; Leone, T.C.; Welch, M.J.; Bennett, M.J.; Kovacs, A.; Han, X.; Gross, R.W.; Kozak, R.; Lopaschuk, G.D.; et al. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J. Clin. Investig. 2002, 109, 121–130.
  66. Gilde, A.J.; van der Lee, K.A.J.M.; Willemsen, P.H.M.; Chinetti, G.; van der Leij, F.R.; van der Vusse, G.J.; Staels, B.; van Bilsen, M. Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 2003, 92, 518–524.
  67. Bellafiore, M.; Battaglia, G.; Bianco, A.; Palma, A. Expression pattern of angiogenic factors in healthy heart in response to physical exercise intensity. Front. Physiol. 2019, 10, 238.
  68. Li, L.; Mühlfeld, C.; Niemann, B.; Pan, R.; Li, R.; Hilfiker-Kleiner, D.; Chen, Y.; Rohrbach, S. Mitochondrial biogenesis and PGC-1α deacetylation by chronic treadmill exercise: Differential response in cardiac and skeletal muscle. Basic Res. Cardiol. 2011, 106, 1221–1234.
  69. Riehle, C.; Abel, E.D. PGC-1 proteins and heart failure. Trends Cardiovasc. Med. 2012, 22, 98–105.
  70. Jia, D.; Hou, L.; Lv, Y.; Xi, L.; Tian, Z. Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1α/PI3K/Akt signaling. J. Cell. Physiol. 2019, 234, 23705–23718.
  71. Radak, Z.; Zhao, Z.; Koltai, E.; Ohno, H.; Atalay, M. Oxygen consumption and usage during physical exercise: The balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid. Redox Signal. 2013, 18, 1208–1246.
  72. Ghiasi, R.; Mohammadi, M.; Ashrafi Helan, J.; Jafari Jozani, S.R.; Mohammadi, S.; Ghiasi, A.; Naderi, R. Influence of two various durations of resistance exercise on oxidative stress in the male rat’s hearts. J. Cardiovasc. Thorac. Res. 2015, 7, 149–153.
  73. Shi, J.; Bei, Y.; Kong, X.; Liu, X.; Lei, Z.; Xu, T.; Wang, H.; Xuan, Q.; Chen, P.; Xu, J.; et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury. Theranostics 2017, 7, 664–676.
  74. Fernandes, T.; Baraúna, V.G.; Negrão, C.E.; Phillips, M.I.; Oliveira, E.M. Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am. J. Physiol. Heart Circ. Physiol. 2015, 309, H543–H552.
  75. Hou, Z.; Qin, X.; Hu, Y.; Zhang, X.; Li, G.; Wu, J.; Li, J.; Sha, J.; Chen, J.; Xia, J.; et al. Longterm exercise-derived exosomal miR-342-5p. Circ. Res. 2019, 124, 1386–1400.
  76. Gao, F.; Kataoka, M.; Liu, N.; Liang, T.; Huang, Z.-P.; Gu, F.; Ding, J.; Liu, J.; Zhang, F.; Ma, Q.; et al. Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction. Nat. Commun. 2019, 10, 1802.
  77. Eulalio, A.; Mano, M.; Ferro, M.D.; Zentilin, L.; Sinagra, G.; Zacchigna, S.; Giacca, M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492, 376–381.
  78. Fan, Y.; Ho, B.X.; Pang, J.K.S.; Pek, N.M.Q.; Hor, J.H.; Ng, S.-Y.; Soh, B.-S. Wnt/β-catenin-mediated signaling re-activates proliferation of matured cardiomyocytes. Stem Cell Res. Ther. 2018, 9, 338.
  79. MacGrogan, D.; Münch, J.; de la Pompa, J.L. Notch and interacting signalling pathways in cardiac development, disease, and regeneration. Nat. Rev. Cardiol. 2018, 15, 685–704.
  80. Heallen, T.; Zhang, M.; Wang, J.; Bonilla-Claudio, M.; Klysik, E.; Johnson, R.L.; Martin, J.F. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332, 458–461.
  81. O’Keefe, J.H.; Patil, H.R.; Lavie, C.J.; Magalski, A.; Vogel, R.A.; McCullough, P.A. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin. Proc. 2012, 87, 587–595.
  82. Bernardo, B.C.; Ooi, J.Y.Y.; Weeks, K.L.; Patterson, N.L.; McMullen, J.R. Understanding key mechanisms of exercise-induced cardiac protection to mitigate disease: Current knowledge and emerging concepts. Physiol. Rev. 2018, 98, 419–475.
  83. Fukazawa, R.; Miller, T.A.; Kuramochi, Y.; Frantz, S.; Kim, Y.D.; Marchionni, M.A.; Kelly, R.A.; Sawyer, D.B. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J. Mol. Cell. Cardiol. 2003, 35, 1473–1479.
  84. Liao, P.H.; Hsieh, D.J.; Kuo, C.H.; Day, C.H.; Shen, C.Y.; Lai, C.H.; Chen, R.J.; Padma, V.V.; Kuo, W.W.; Huang, C.Y. Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts. Oncotarget 2015, 6, 35383–35394.
  85. Lin, C.H.; Lin, C.C.; Ting, W.J.; Pai, P.Y.; Kuo, C.H.; Ho, T.J.; Kuo, W.W.; Chang, C.H.; Huang, C.Y.; Lin, W.T. Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts. Age 2014, 36, 9705.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 531
Revisions: 3 times (View History)
Update Date: 04 Jan 2021
Video Production Service